All articles tagged: Neoplasm of unspecified behavior of breast (D49.3)
HealthDay
04 January at 03.52 PM
Artificial Intelligence Risk Model Validated for Predicting Breast CancerAcross European populations, an artificial intelligence (AI) risk model shows generalizable discriminatory performance for predicting breast cancer among women with a negative mammogram, according to a study published online Dec. 6 in The Lancet Regional Health: Europe.Mikael Eriksson, Ph.D., from the Karolinska Institutet in Stockholm |
|
HealthDay
19 December at 04.18 PM
San Antonio Breast Cancer Symposium, Dec. 5 to 9The annual San Antonio Breast Cancer Symposium was held from Dec. 5 to 9 in San Antonio, with attendees including medical oncologists, radiation oncologists, researchers, and other health care professionals. The conference highlighted recent advances in the risk, diagnosis, treatment, and prevention of breast cancer, and presentations focused on emerging tr |
|
HealthDay
11 December at 04.41 PM
SABCS: Serum Hormones Can Help ID Benefit of AnastrozoleSerum hormone concentrations can help ascertain which women with breast cancer will benefit from anastrozole treatment, according to a study published online Dec. 6 in The Lancet Oncology to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 5 to 9 in San Antonio.Jack Cuzick, Ph.D., from Queen Mary University o |
|
HealthDay
07 December at 11.01 PM
SABCS: Younger Postmenopausal Breast Cancer Patients Can Avoid Adjuvant RTFor postmenopausal women aged 50 to 69 years with stage 1 hormone receptor-positive breast cancer, the risk for recurrence is very low for those who do not undergo radiotherapy after breast-conserving surgery (BCS), according to a study published online Dec. 7 in the Journal of Clinical Oncology to coincide with the annual San Antonio Breast |
|
HealthDay
01 December at 04.44 PM
ASTRO Issues Guidance Related to Partial Breast IrradiationIn a clinical practice guideline issued by the American Society for Radiation Oncology (ASTRO) published online Nov. 15 in Practical Radiation Oncology, recommendations are presented to inform best clinical practices on the use of partial breast irradiation (PBI).Simona F. Shaitelman, M.D., from the University of Texas MD Anderson Cancer |
Medical xPress
08 July at 06.16 AM
Scientists create first mouse model with complete, functional human immune systemA breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of mounting specific antibody responses. |
|
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
|
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
|
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
|
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
|
|
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
|
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
|
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
|
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
